Dutasteride/Tamsulosin (Jalyn) for Benign Prostatic Hyperplasia

被引：0

作者：

Wilson, Stephen A. ^{[1
]}

Broders, Jennie ^{[1
]}

机构：

[1] Univ Pittsburgh Family Med Residency, Pittsburgh, PA USA

来源：

AMERICAN FAMILY PHYSICIAN | 2012年 / 85卷 / 12期

关键词：

D O I：

暂无

中图分类号：

R1 [预防医学、卫生学];

学科分类号：

1004 ; 120402 ;

摘要：

引用

页码：1194 / 1195

页数：2

共 50 条

[31] The effects of dutasteride, tamsulosin, and the combination on storage and voiding in men with benign prostatic hyperplasia and prostatic enlargement: 2-year results from the Combination of Avodart and Tamsulosin study
E Becher
C G Roehrborn
P Siami
R P Gagnier
T H Wilson
F Montorsi
Prostate Cancer and Prostatic Diseases, 2009, 12 : 369 - 374
[32] Effect of Discontinuation of Tamsulosin in Korean Men with Benign Prostatic Hyperplasia Taking Tamsulosin and Dutasteride: An Open-Label, Prospective, Randomized Pilot Study
Lee, Joo Yong
Kang, Dong Hyuk
Park, Sung Yul
Lee, Seung Wook
Kim, Yong Tae
Choi, Hong Yong
Moon, Hong Sang
LUTS-LOWER URINARY TRACT SYMPTOMS, 2012, 4 (01) : 35 - 40
[33] Triple Therapy with Tamsulosin, Dutasteride, and Imidafenacin for Benign Prostatic Hyperplasia in Patients with Overactive Bladder Symptoms Refractory to Tamsulosin: Subgroup Analyses of the DIrecT Study
Yamanishi, Tomonori
Asakura, Hirotaka
Seki, Narihito
Tokunaga, Shoji
UROLOGIA INTERNATIONALIS, 2021, 105 (9-10) : 817 - 825
[34] Management of benign prostatic hyperplasia - Defining the role of tamsulosin
Croom, KF
Wagstaff, AJ
DISEASE MANAGEMENT & HEALTH OUTCOMES, 2004, 12 (05) : 337 - 350
[35] Cost-effectiveness of single-dose tamsulosin and dutasteride combination therapy compared with tamsulosin monotherapy in patients with benign prostatic hyperplasia in the UK
Walker, Anna
Doyle, Scott
Posnett, John
Hunjan, Manjit
BJU INTERNATIONAL, 2013, 112 (05) : 638 - 646
[36] A combination of dutasteride, a 5α-reductase inhibitor, and tamsulosin, an alpha-adrenergic antagonist for the treatment of symptomatic benign prostatic hyperplasia
不详
FORMULARY, 2010, 45 (09) : 272 - 272
[37] COMPARISON OF BENIGN PROSTATIC HYPERPLASIA OUTCOMES IN THE COMBINATION OF AVODART AND TAMSULOSIN (COMBAT) AND REDUCTION OF DUTASTERIDE IN CANCER EVENTS (REDUCE) STUDIES
Roehrborn, Claus G.
Montorsi, Francesco
Brawley, Otis W.
Wilson, Timothy H.
Rittmaster, Roger S.
Castro, Ramiro
JOURNAL OF UROLOGY, 2011, 185 (04): : E790 - E790
[38] Review of dutasteride/tamsulosin fixed-dose combination for the treatment of benign prostatic hyperplasia: efficacy, safety, and patient acceptability
Barkin, Jack
PATIENT PREFERENCE AND ADHERENCE, 2011, 5 : 483 - 490
[39] Effect of combination treatment on patient-related outcome measures in benign prostatic hyperplasia: clinical utility of dutasteride and tamsulosin
Djavan, Bob
Dianat, Seyed Saeid
Kazzazi, Amir
PATIENT-RELATED OUTCOME MEASURES, 2011, 2 : 71 - 79
[40] DUTASTERIDE/TAMSULOSIN FIXED-DOSE COMBINATION FOR THE TREATMENT OF BENIGN PROSTATIC ENLARGEMENT
Ismail, M.
Hashim, H.
DRUGS OF TODAY, 2012, 48 (01) : 17 - 24

← 1 2 3 4 5 →